| Stage | TMO | % of rev | ABT | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $12.1B | 100.00% | $13.0B | 100.00% | ABT ×1.07 |
| Gross profit | $5.1B | 42.28% | $7.4B | 56.75% | ABT +14.5pp |
| Operating income | $2.3B | 18.65% | $1.4B | 10.44% | TMO +8.2pp |
| Pre-tax income | $2.1B | 17.20% | $1.2B | 9.46% | TMO +7.7pp |
| Net income | $1.7B | 14.23% | $920M | 7.07% | TMO +7.2pp |
| Stage | TMO | ABT | Gap · A − B |
|---|---|---|---|
| Revenue | $12.1B100.00% | $13.0B100.00% | ABT ×1.07 |
| Gross profit | 42.28%$5.1B | 56.75%$7.4B | ABT +14.5pp |
| Operating income | 18.65%$2.3B | 10.44%$1.4B | TMO +8.2pp |
| Pre-tax income | 17.20%$2.1B | 9.46%$1.2B | TMO +7.7pp |
| Net income |
| 14.23%$1.7B |
| 7.07%$920M |
| TMO +7.2pp |
No shared counterparties.